EQ-5D-5L versus EQ-5D-3L: The Impact on Cost Effectiveness in the United Kingdom

Monica Hernandez Alava, Allan Wailoo*, Sabine Grimm, Stephen Pudney, Manuel Gomes, Zia Sadique, David Meads, John O'Dwyer, Garry Barton, Lisa Irvine

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)49-56
Number of pages8
JournalValue in Health
Volume21
Issue number1
DOIs
Publication statusPublished - 1 Jan 2018

Keywords

  • cost effectiveness
  • EQ-5D
  • health utility
  • RANDOMIZED CONTROLLED-TRIAL
  • EARLY RHEUMATOID-ARTHRITIS
  • VALUE SET
  • HEALTH STATES
  • DISEASE
  • GLUCOCORTICOIDS
  • DRUGS

Cite this